Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline ...

Advocate Health is scaling clinical trial network across six states to integrate research into routine care at ...

Cross-industry collaborations ease the kinds of friction that have accumulated over many years, allowing organizations to devote more of their creativity to the scientific and operational issues that ...

The Rapid RCT Lab is a nationally-leading team conducting innovative, rapid RCTs to improve the delivery of services at the ...

Melissa L. Johnson, MD, is now chief scientific officer while retaining leadership of lung cancer research, and Erika P. Hamilton, MD, is now chief development officer, late phase, while remaining the ...

Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 Earnings Call Transcript February 12, 2026 Aethlon Medical, Inc. misses on ...

Kivo reports AI accelerates cancer research by analyzing large datasets, improving clinical trial matching, and expediting biomarker discovery.

Electrocatalysis sits at the heart of clean hydrogen production, fuel cells, and carbon dioxide conversion, yet progress ...

Much of what keeps science accurate, ethical, and usable is done by women and girls—and because it doesn’t look like a ...

Regarding the industry's talent pipeline, Dr. de Miguel highlights the importance of education programs in the fields of science, technology, engineering, and mathematics (STEM) in building the ...

Taking a collaborative approach to customs can transform characterization by applying standard techniques and translating scientific intent into tailored spectroscopy solutions.

Pioneering biostatistician and infectious disease expert Dr. Elizabeth Halloran recently transitioned to emerita after a 40-year career shaping the design and analysis of vaccine trials and pandemic ...